NCT04216888: Biomarkers of Response to Ketamine in Depression: MRI and Blood Assays Before and After Open Label Intranasal Ketamine
- State
- Completed
- Phase
- Phase 2 and Phase 3
- People
- 9 taking part
- Started
- 26 Jun 2019
- Primary completion
- 28 Dec 2020
- Arms
- Open label
- Results
- None posted
- 26 Jun 2019: Trial started
- 3 Jan 2020: Trial registered
- 28 Dec 2020: Trial completed